Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
(5Z,8Z,14Z)-11,12-epoxyeicosa-5,8,14-trienoate, (5Z,8Z,14Z)-11,12-epoxyeicosa-5,8,14-trienoic acid, (5Z,8Z,14Z)-11,12-epoxyeicosatrienoic acid, 11,12-epoxy-(5Z,8Z,14Z)-eicosatrienoic acid, 11,12-epoxy-eicosatrienoic acid, 11,12-epoxyeicosatrienoate
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(5Z,8Z,14Z)-11,12-epoxyeicosa-5,8,14-trienoic acid + H2O = (5Z,8Z,14Z)-11,12-dihydroxyeicosa-5,8,14-trienoic acid
-
(5Z,8Z,14Z)-11,12-epoxyeicosatrienoic acid + H2O = (5Z,8Z,14Z)-11,12-dihydroxyeicosatrienoic acid
-
11,12-epoxy-eicosatrienoic acid + H2O = 11,12-dihydroxy-eicosatrienoic acid
-
(5Z,8Z,14Z)-11,12-epoxyeicosa-5,8,14-trienoic acid + H2O = (5Z,8Z,14Z)-11,12-dihydroxyeicosa-5,8,14-trienoic acid
-
(5Z,8Z,14Z)-11,12-epoxyeicosatrienoic acid + H2O = (5Z,8Z,14Z)-11,12-dihydroxyeicosatrienoic acid
-
11,12-epoxyeicosatrienoate + H2O = 11,12-hydroxyeicosatrienoate
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Protein phosphatase 2A and Ca2+-activated K+ channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation
2007
Dimitropoulou, C.; West, L.; Field, M.B.; White, R.E.; Reddy, L.M.; Falck, J.R.; Imig, J.D.
Prostaglandins Other Lipid Mediat.
83
50-61
Mammalian epoxide hydrolases in xenobiotic metabolism and signalling
2009
Decker, M.; Arand, M.; Cronin, A.
Arch. Toxicol.
83
297-318
Soluble epoxide hydrolase homologs in Strongylocentrotus purpuratus suggest a gene duplication event and subsequent divergence
2008
Harris, T.R.; Aronov, P.A.; Hammock, B.D.
DNA Cell Biol.
27
467-477
Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response
2008
Keserue, B.; Barbosa-Sicard, E.; Popp, R.; Fisslthaler, B.; Dietrich, A.; Gudermann, T.; Hammock, B.D.; Falck, J.R.; Weissmann, N.; Busse, R.; Fleming, I.
FASEB J.
22
4306-4315
Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model
2008
Ulu, A.; Davis, B.B.; Tsai, H.J.; Kim, I.H.; Morisseau, C.; Inceoglu, B.; Fiehn, O.; Hammock, B.D.; Weiss, R.H.
J. Cardiovasc. Pharmacol.
52
314-323
Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats
2009
Revermann, M.; Barbosa-Sicard, E.; Dony, E.; Schermuly, R.T.; Morisseau, C.; Geisslinger, G.; Fleming, I.; Hammock, B.D.; Brandes, R.P.
J. Hypertens.
27
322-331
Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation
2008
Fife, K.L.; Liu, Y.; Schmelzer, K.R.; Tsai, H.J.; Kim, I.H.; Morisseau, C.; Hammock, B.D.; Kroetz, D.L.
J. Pharmacol. Exp. Ther.
327
707-715
Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids
2008
Yan, G.; Chen, S.; You, B.; Sun, J.
Cardiovasc. Res.
78
308-314
Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids
2010
Crow, J.A.; Herring, K.L.; Xie, S.; Borazjani, A.; Potter, P.M.; Ross, M.K.
Biochim. Biophys. Acta
1801
31-41
Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth
2009
Oguro, A.; Sakamoto, K.; Suzuki, S.; Imaoka, S.
Biol. Pharm. Bull.
32
1962-1967
Soluble epoxide hydrolase, a target with multiple opportunities for cardiovascular drug discovery
2009
Marino, J.P.
Curr. Top. Med. Chem.
9
452-463
Soluble epoxide hydrolase inhibition: targeting multiple mechanisms of ischemic brain injury with a single agent
2009
Iliff, J.J.; Alkayed, N.J.
Future Neurol.
4
179-199
Inhibition of soluble epoxide hydrolase by trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury
2010
Chaudhary, K.R.; Abukhashim, M.; Hwang, S.H.; Hammock, B.D.; Seubert, J.M.
J. Cardiovasc. Pharmacol.
55
67-73
Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase
2009
Eldrup, A.B.; Soleymanzadeh, F.; Taylor, S.J.; Muegge, I.; Farrow, N.A.; Joseph, D.; McKellop, K.; Man, C.C.; Kukulka, A.; De Lombaert, S.
J. Med. Chem.
52
5880-5895
Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation
2010
Deng, Y.; Theken, K.N.; Lee, C.R.
J. Mol. Cell. Cardiol.
48
331-341
Development of a high throughput cell-based assay for soluble epoxide hydrolase using BacMam technology
2010
Xie, W.; Tang, X.; Lu, Q.; Ames, R.S.; Ratcliffe, S.J.; Li, H.
Mol. Biotechnol.
45
207-217
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
2009
Imig, J.D.; Hammock, B.D.
Nat. Rev. Drug Discov.
8
794-805
Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism
2009
Marowsky, A.; Burgener, J.; Falck, J.R.; Fritschy, J.M.; Arand, M.
Neuroscience
163
646-661
Probing the orientation of inhibitor and epoxy-eicosatrienoic acid binding in the active site of soluble epoxide hydrolase
2017
Lee, K.S.; Henriksen, N.M.; Ng, C.J.; Yang, J.; Jia, W.; Morisseau, C.; Andaya, A.; Gilson, M.K.; Hammock, B.D.
Arch. Biochem. Biophys.
613
1-11
Microsomal epoxide hydrolase 1 (EPHX1) Gene, structure, function, and role in human disease
2015
Vaclavikova, R.; Hughes, D.J.; Soucek, P.
Gene
571
1-8